OPTI.LSE OptiBiotix Health Plc

Healthcare Biotechnology London Exchange
0.0560 GBX
Close of Nov 3, 2026
4.50 9.00
Market cap
GBX 5.78M
P/E
-
P/B
1.27x
ROE
-133.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is OPTI.LSE undervalued?

Graham number

The Graham number of OptiBiotix Health Plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

OptiBiotix Health Plc fundamental analysis

No fundamental analysis for OptiBiotix Health Plc yet.

OptiBiotix Health Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About OptiBiotix Health Plc

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its first-generation products include Slimbiome, which offers …

Full company profile